Associate Professor at the Medical University of Innsbruck. We are interested in the mechanistic function and structure of antimicrobial/antifungal proteins and peptides and the identification of target molecules for the development of new antimicrobial/antifungal therapies.
CIFAR Azrieli Global Scholar and Tier 2 Canada Research Chair in Gut Microbial Physiology in the Department of Microbiology and Immunology at McGill University. Board member of the Microbiome and Disease Tolerance Centre.
Research in our lab aims to address two major goals:
* Identify and characterize the metabolically active microbial members of the gut microbiota.
* Determine the role of bacteriophages as regulators of the active gut microbiota.
BSc (Hons) University of Ulster, PhD Liverpool University. Postdoc and NERC Advanced Research Fellow at Warwick University. I have been at the University of Waikato since 2004 and was promoted to Associate Professor in 2010. My research has focused on the microbial ecology of methane oxidation, Antarctica and geothermal environments in New Zealand. In Antarctica we are studying the drivers of microbial diversity in Dry Valley soils, geothermal environments (Mts Erebus, Melbourne and Rittmann), and terrestrial meltwater ponds. Currently ‘The 1000 Spring project’ is determining drivers of microbial diversity in NZ geothermal environments. I have organized several NZ and international conferences, am on the LOC for PAM 2019 in Hamilton. I am on the editorial board for ISMEJ.
Associate professor in the Department of Biology at Pennsylvania State University. Recipient of the Pecase Award in 2008 and the Guggenheim Award in 2011.
John Mekalanos is the Adele H. Lehman Professor of Microbiology and Molecular Genetics at Harvard Medical School. He has served as Chair of the Microbiology and Molecular Genetics Department since 1996, and he is a member of the National Academy of Sciences and the American Academy of Microbiology.
Dr. Mekalanos has received amongst other honors the Eli Lilly Award and American Association for the Advancement of Science Newcomb Cleveland Prize for the Outstanding Paper of 1993 Published in Science (259:686-688, 1993). He has been a member of the FDA Advisory Committee on Vaccines and Related Biologics, and has consulted for numerous other governmental and private agencies, including NIH, DOD, the World Health Organization, The International Vaccine Institute, the National Academy of Sciences, Massachusetts Public Health Biological Laboratories, and the US-Japan Cooperative Medical Science Program. Dr. Mekalanos has been an active consultant in the pharmaceutical industry for companies including SmithKline, Merck, and Vicuron, and he was a co-founder of three biotechnology firms (Virus Research Institute, PharmAthene and most recently, Matrivax). He received the Sanofi-Institut Pasteur 2012 Award. He and his group have published over 200 research articles, and he has supervised more than 50 trainees in his lab during his career thus far.
As a seagoing oceanographer and plankton ecologist, I focus my research efforts on examining how microscopic organisms affect the biogeochemistry of the ocean, particularly predator prey interactions of singled celled eukaryotic microplankton. After receiving a ‘Diploma’ in Biology from the University of Bonn, with research done at the Alfred Wegener Institute in Bremerhaven, Germany, I pursued M.Sc. and Ph.D. degrees in Oceanography at the University of Washington. Before becoming a faculty member at the Graduate School of Oceanography at the University of Rhode Island was a lecturer at Western Washington University’s Shannon Point Marine Center and a research fellow at Princeton University.
Rikke Meyer is associate professor of microbiology at the Interdisciplinary Nanoscience Center at Aarhus University, Denmark. Her research combines microbiology and nanoscience in the pursuit of understanding how bacteria attach to surfaces and form biofilm, and how these can be prevented or treated through novel formulations of antimicrobial compounds or antifouling surfaces.
Auxiliary Researcher at Laboratory of Bacterial Evolution and Molecular Epidemiology, Instituto de Tecnologia Quimica e Biologica, Universidade Nova de Lisboa, Portugal. Recipient of the 2010 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Grant and of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Infectious Diseases fellows Award.
Robert W. Woodruff Professor of Microbiology and Immunology in the Emory Vaccine Center at Emory University (since 2006). Formerly Professor and Chair of Microbiology & Immunology at Stanford University (1983 - 2006; now Emeritus). Previously (2009 and 2010), Distinguished Fellow at MedImmune, LLC, a wholly owned subsidiary of AstrZeneca.
Associate Professor of Marine Science, Red Sea Research Center, King Abdullah University of Science and Technology (KAUST), Saudi Arabia. I was senior researcher at the Spanish Institute of Oceanography (IEO) in Gijón/Xixón from 2001 to 2014, after my PhD training at the Institute of Marine Sciences (ICM-CSIC) in Barcelona. I am a biological oceanographer and microbial ecologist addressing the role of microbial plankton in biogeochemical carbon cycling from different perspectives. My research interests include the trophic relationships between phytoplankton and heterotrophic prokaryotes, the long-term dynamics of planktonic microorganisms and their response to global change, with particular emphasis on warming using the metabolic ecology framework. I combine experimental approaches with large-scale observations, both spatial and temporal, in order to predict the future direction and extent of change in the structure and functioning of marine microbial food webs.
Dr. Moreau is a geomicrobiologist who studies how microorganisms influence the form and mobility of nutrients and contaminants in soil, sediments and groundwater. He is particularly interested in the roles of iron- and sulfur-cycling bacteria, and their interactions with toxic metals such as mercury, arsenic and uranium. His group works on problems involving microbes in wetlands, mines, hot springs, the ocean, and the deep subsurface, and employs a range of techniques including metagenomics, electron microscopy, and synchrotron spectroscopy. Moreau obtained his Ph.D from the University of California, Berkeley in 2006, was a U.S. National Research Council Postdoctoral Fellow at the U.S. Geological Survey from 2006-2008, and is currently a Sr. Lecturer and Director of the Environmental Microbiology Research Initiative (EMRI) at the University of Melbourne.
Dr. Hilary Morrison is a molecular biologist with graduate and postgraduate training in virology and infectious disease epidemiology. She is a senior research scientist at the MBL with research interests in parasite genomics, microbial ecology, and sequencing technology. She led the project to sequence, assemble, and annotate the Giardia lamblia genome, published in Science in 2007. Giardia, as well as being a medically important human parasite, is an enigmatic microbe that exhibits an early divergence in the eukaryotic domain of life. Morrison was part of an MBL team that developed pyrotag sequencing, a method for defining microbial population structures using high-throughput next generation instruments to sequence short regions of the ribosomal RNA gene. She has been instrumental in obtaining and developing protocols for new sequencing technologies and developing new software tools and pipelines. She was part of a multi-institutional team that developed a transposon-based next-generation library construction technique. Morrison collaborates on diverse microbiome projects including the gut and lung microbiomes of cystic fibrosis patients and the macroalgal microbiome across time and space.